Skip to main content
. 2020 Aug 11;11(32):3026–3034. doi: 10.18632/oncotarget.27688

Table 2. Predictors of case fatality and recurrence.

Risk of death Risk of local in-brain recurrence
OR CI (5–95%) p-value OR CI (5–95%) p-value
Baseline Age ≤ 65 years 0.69 0.28 1.38 0.435 3.40 1.02 11.37 0.047
Male sex 1.76 0.63 4.93 0.280 1.06 0.31 3.70 0.924
KPS > 70 0.19 0.06 0.63 0.007 1.49 0.42 5.35 0.540
Histology NSCLC Ref Ref Ref 0.014 Ref Ref Ref 0.082
GIT 2.28 0.39 13.14 0.358 6.73 0.56 81.60 0.134
Breast 0.48 0.12 1.94 0.300 16.19 1.48 177.74 0.023
Melanoma 0.31 0.08 1.21 0.092 29.63 3.11 282.41 0.003
SCLC 7.27 0.76 69.82 0.086 11.73 1.05 131.09 0.046
Other 0.12 0.02 0.55 0.007 8.98 0.72 112.65 0.89
Systemic Not Disseminated 0.96 0.39 2.39 0.930 1.36 0.48 3.86 0.568
Radiological Eloquent 0.97 0.36 2.67 0.959 0.70 0.21 2.34 0.565
Diameter ≤ 30 mm 0.32 0.12 0.81 0.017 1.19 0.42 3.35 0.742
Single brain lesion 0.12 0.04 0.33 < 0.001 1.19 0.42 3.43 0.740
Infratentorial 0.38 0.14 1.04 0.061 0.70 0.21 2.34 0.565
Surgical 5-ALA 0.71 0.27 1.85 0.485 0.59 0.18 1.99 0.400